Canada Life’s Nikola Corporation Common Stock NKLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,367
Closed -$321K 2140
2024
Q1
$321K Buy
10,367
+7,852
+312% +$169K ﹤0.01% 1764
2023
Q4
$66K Buy
2,515
+975
+63% +$30.3K ﹤0.01% 2018
2023
Q3
$73K Buy
1,540
+906
+143% +$47.1K ﹤0.01% 2025
2023
Q2
$26K Hold
634
﹤0.01% 2105
2023
Q1
$23K Hold
634
﹤0.01% 2189
2022
Q4
$41K Buy
634
+191
+43% +$16K ﹤0.01% 2118
2022
Q3
$47K Hold
443
﹤0.01% 2109
2022
Q2
$63K Sell
443
-22,486
-98% -$4.6M ﹤0.01% 2011
2022
Q1
$7.54M Sell
22,929
-1,126
-5% -$287K 0.02% 653
2021
Q4
$7.12M Buy
24,055
+23,769
+8,311% +$7.93M 0.01% 670
2021
Q3
$92K Hold
286
﹤0.01% 2072
2021
Q2
$155K Sell
286
-8,131
-97% -$3.39M ﹤0.01% 1991
2021
Q1
$3.51M Buy
8,417
+3,688
+78% +$2.1M 0.01% 823
2020
Q4
$2.16M Buy
+4,729
New +$2.95M ﹤0.01% 1093

Other funds holding NKLA

Canada Life's NKLA Position: Q2 2024 in Review

Canada Life sold out of Nikola Corporation Common Stock (NKLA) in Q2 2024, closing a stake of 10,367 shares — an estimated $321K sold.

Canada Life first reported a position in NKLA in Q4 2020 and held it in 14 quarters. The position peaked at $7.54M in Q1 2022. 159 funds tracked by Wall St. Rank hold NKLA as of Q2 2024.

  • Canada Life reported no remaining Nikola Corporation Common Stock position as of Q2 2024 after selling out during the quarter.
  • Canada Life sold 10,367 Nikola Corporation Common Stock shares in Q2 2024, an estimated $321K.
  • Canada Life first reported a position in Nikola Corporation Common Stock in Q4 2020 and held it in 14 quarters.
  • Canada Life's Nikola Corporation Common Stock position peaked at $7.54M in Q1 2022.
  • 159 funds tracked by Wall St. Rank held Nikola Corporation Common Stock as of Q2 2024.

Based on Canada Life's 13F filing for Q2 2024, filed 12 Aug 2024.